Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application.

ABSTRACT:

SUBMITTER: Sadremomtaz A 

PROVIDER: S-EPMC7272640 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature